上海儒百生物(Schbio Biotech)
专业血液免疫学产品生产商

Product Description
Human 4-1BB / TNFRSF9 Protein, Human Fc tag
在线客服
Brand : RecProtein®
Synonym : TNFRSF9,4-1BB,CD137,CDw137,ILA
Molecule : 4-1BB
Catalog : B1434
Qty : 1mg, 5mg
18521561575  需求咨询
Datasheet

Source

Human 4-1BB, Fc Tag   (H-41BB-3)   is expressed from human 293 cells (HEK293). It contains AA Gln 25 - Gln 186 (Accession # NP_001552.2).

Predicted N-terminus: Gln 25


Molecular Characterization

This protein carries a human IgG1 Fc tag at the C-terminus.


Endotoxin

Less than 0.01 EU/μg by the LAL method.


Purity

>95% as determined by SDS-PAGE.


Bioactivity

ELISA

BIACORE (With our Research Grade Biosimilar Antibody products);


Formulation

Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, pH7.5. Normally trehalose is added as protectant before lyophilization.


Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.


Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

No activity loss was observed after storage at:

4-8°C for 12 months in lyophilized state;

-70°C for 3 months under sterile conditions after reconstitution.


Background

4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.


Reference

(1) Cooper D, et al., 2002, Eur. J. Immunol. 32 (2): 521–9.

(2) Jang, I K., et al., 1998, Biochem. Biophys. Res. Commun. (UNITED STATES) 242 (3): 613–20.

(3) Arch, R H., Thompson C B., 1998, Mol. Cell. Biol. (UNITED STATES) 18 (1): 558–65.



会员登录
登录
其他帐号登录:
留言
回到顶部